Michael P Pender
Michael P Pender
Emeritus Professor, Faculty of Medicine, The University of Queensland
Verified email at
Cited by
Cited by
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
M Bahlo, DR Booth, SA Broadley, MA Brown, SJ Foote, LR Griffiths, ...
Nature Genetics 41 (7), 824-828, 2009
Sun exposure and vitamin D are independent risk factors for CNS demyelination
RM Lucas, AL Ponsonby, K Dear, PC Valery, MP Pender, BV Taylor, ...
Neurology 76 (6), 540-548, 2011
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci
NA Patsopoulos, ...
Annals of neurology 70 (6), 897-912, 2011
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases
MP Pender
Trends in immunology 24 (11), 584-588, 2003
Apoptosis in the nervous system in experimental allergic encephalomyelitis
MP Pender, KB Nguyen, PA McCombe, JFR Kerr
Journal of the neurological sciences 104 (1), 81-87, 1991
CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis
MP Pender
Autoimmune diseases 2012, 2012
Epstein–Barr virus in multiple sclerosis: theory and emerging immunotherapies
A Bar-Or, MP Pender, R Khanna, L Steinman, HP Hartung, T Maniar, ...
Trends in molecular medicine 26 (3), 296-310, 2020
Immunology of multiple sclerosis
MP Pender, JM Greer
Current allergy and asthma reports 7 (4), 285-292, 2007
Immune dysregulation and self-reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?
AL Jones, BJ Mowry, MP Pender, JM Greer
Immunology and Cell biology 83 (1), 9-17, 2005
The essential role of Epstein-Barr Virus in the pathogenesis of multiple sclerosis
MP Pender
The Neuroscientist 17 (4), 351-367, 2011
Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population
L Tajouri, M Ovcaric, R Curtain, MP Johnson, LR Griffiths, P Csurhes, ...
Journal of neurogenetics 19 (1), 25-38, 2005
Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis
BT Sadatipour, JM Greer, MP Pender
Annals of Neurology: Official Journal of the American Neurological …, 1998
Apoptosis of inflammatory cells in immune control of the nervous system: role of glia
MP Pender, MJ Rist
Glia 36 (2), 137-144, 2001
Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study
AL Ponsonby, RM Lucas, IA Van Der Mei, K Dear, PC Valery, MP Pender, ...
Neurology 78 (12), 867-874, 2012
Epstein–Barr virus and multiple sclerosis
RM Lucas, AM Hughes, MLJ Lay, AL Ponsonby, DE Dwyer, BV Taylor, ...
Journal of Neurology, Neurosurgery & Psychiatry 82 (10), 1142-1148, 2011
Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy
MP Pender, SR Burrows
Clinical & translational immunology 3 (10), e27, 2014
Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
MP Pender, PA Csurhes, C Smith, NL Douglas, MA Neller, KK Matthews, ...
JCI insight 3 (22), 2018
Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis
MP Pender
The Lancet 351 (9107), 978-981, 1998
Defective T‐cell control of Epstein–Barr virus infection in multiple sclerosis
MP Pender, PA Csurhes, JM Burrows, SR Burrows
Clinical & translational immunology 6 (1), e126, 2017
The occurrence of autoimmune diseases in patients with multiple sclerosis and their families
RD Henderson, CJ Bain, MP Pender
Journal of Clinical Neuroscience 7 (5), 434-437, 2000
The system can't perform the operation now. Try again later.
Articles 1–20